Ono Pharma Cash Flow - Quarterly (OTCMKTS:OPHLF)

Add to My Stocks
$23.15 $0 (0%) OPHLF stock closing price Sep 18, 2018 (Closing)

The financial analysis of OPHLF requires an investor to check the cash flows for Ono Pharma. The profit-loss statement shows Ono Pharma profits, the balance sheet shows Ono Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Ono Pharma had cash and cash equivalents of $986.47M at beginning of the quarter and $351.4M at quarter end of 2018 Q3. Ono Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. The cash from operating activities for Ono Pharma is $ 2018 Q3, which saw an increase from previous quarter.

View and download details of Ono Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar2018 Q32018 Q12017 Q42017 Q32017 Q12016 Q4
Net Income Cash Flow
489.66M141.03M665.53M484.41M178.86M297.06M
Depreciation Depletion Amortization Cash-Flow59.12M19.79M69.82M48.71M16.46M58.34M
Net Increase (Decrease) in Assets Liabilities-207.99M-42.74M-32.81M-179.48M-175.71M-135.39M
Cash From (used in) Discontinued Operations------
Other Adjustments Net-416.34M-285.3M-37.81M-33.32M--105.34M
Net Cash from (used by) Operating Activities
-75.54M-167.21M664.73M320.33M20.31M114.66M
Increase (Decrease) in Prop Plant And Equipment42.22M-25.39M-129.73M-108.68M-85.79M-54.32M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments-0.35M35.35M228.94M171.58M58.82M239.55M
Other Cash Inflow (Outflow) from Investment Activities-365.98M-38.79M-259.82M-230.37M-6.67M-68.82M
Net Cash from (used by) Investment Activities
-324.11M-28.83M-160.61M-167.47M-33.64M116.4M
Issuance (Purchase) of Equity Shares-343.14M-200.88M-0.19M-0.18M-0.2M-0.43M
Issuance (Repayment) of Debt Securities-2.78M-0.92M-3.55M-2.49M-0.92M-3.26M
Increase (Decrease) in Bank & Other Borrowings-0.21M--0.1M-0.31M-0.11M-
Payment of Dividends & Other Cash Distributions-198.92M-0.03M-179.6M-166.78M-85.29M-170.16M
Other Cash from (used by) Financing Activities-0.02M-83.12M-0.03M-0.03M-0.03M-0.02M
Net Cash from (used by) Financing Activities
-545.09M-284.8M-183.49M-169.82M-86.56M-173.79M
Effect of Exchange Rate Changes on Cash1.25M--0.63M-0.12M-1.99M-1.35M
Net Change in Cash & Cash Equivalents
-943.49M-480.65M319.98M-17.08M-101.89M55.91M
Cash & Equivalents at Beginning of Year986.47M874.14M873.69M904.96M--
Cash & Equivalents at Year End351.4M825.81M1.31B935.36M981.28M986.47M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Gilead Sciences financial analysis

While Ono Pharma stock price history provides the price history of a stock, Ono Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Ono Pharma had a Net Change in Cash and Cash Equivalents of $-943.49M in the latest quarter 2018 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Ono Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Ono Pharma reported a negative operating cash flow of $-75.54M till 2018 Q3 and has seen an increase from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-324.11M for OPHLF stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-545.09M for Ono Pharma.

Key Financial Ratios For Ono Pharma Cash Flow

Quarterly Cash Flow Statements For ONO PHARMACEUTICAL NPV Peers

Astellas Pharma cash flow, CSPC Pharma cash flow, Gilead Sciences cash flow, Merck KGAA cash flow